Position in ENLV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,218
+$2,494 QoQ
Shares Held
10,988
0.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENLV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. ENLV ranks #80 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,129 | $330,016,949 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,522 | $246,276,633 | |
| 3 | TECH |
BIO-TECHNE Corp
|
3,340,837 | $174,592,141 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
3,590,586 | $64,199,677 | |
| 5 | INSM |
INSMED Inc
|
270,700 | $44,264,863 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
443,272 | $33,285,294 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,496 | $30,935,021 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
480,740 | $25,344,612 |
All Filings in ENLV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,218 | 10,988 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,724 | 10,988 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,427 | 10,988 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $12,306 | 10,988 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $13,580 | 14,000 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||